Jeffrey A. Leerink

Jeffrey A. Leerink is the Chairman and Chief Executive Officer of Leerink Partners, the largest independent investment bank dedicated exclusively to healthcare. Since its founding three decades ago, Leerink Partners has emerged as a leading investment bank known for its expertise in equity research, equity capital markets, and M&A. Under his leadership, Leerink Partners has earned a reputation as a trusted partner to healthcare clients and investors, helping them achieve their strategic and financial objectives in a complex, rapidly evolving industry.

Mr. Leerink co-founded MEDACorp in 1996, a provider of insights on the commercial potential of biotherapeutics and medical devices to healthcare companies and investors. Today, MEDACorp continues providing industry and market insights to Leerink Partners and its clients. In 2008, he co-founded Humedica, Inc., a clinical intelligence company that was later acquired by Optum, a subsidiary of UnitedHealth Group, in 2013. Mr. Leerink founded Leerink Capital Partners in 2013, a healthcare-focused, multi-strategy asset management firm, and in 2019, its private equity funds were integrated into SVB Capital. In 2019, Mr. Leerink led the sale of Leerink Partners to Silicon Valley Bank. He served as CEO of SVB Securities until 2023, when he led a successful management buyout, restoring Leerink Partners’ independence.

Mr. Leerink is committed to advancing healthcare and education through both his professional and philanthropic endeavors. His commitment to the healthcare industry extends to numerous advisory roles and board memberships of healthcare companies. Mr. Leerink is the Vice Chair of the Harvard Medical School Board of Fellows, and he also serves on the Board of Big Brothers Big Sisters of Eastern Massachusetts.

Mr. Leerink holds a B.A. in Economics from Union College.